Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Severe Late Toxicities (Grade 3-5) With 13 Years of Follow-up after Hypofractionated Postprostatectomy Radiotherapy.
Journal: International journal of radiation oncology, biology, physics
Published: January 20, 2025
Optimal management of radiation pneumonitis: Findings of an international Delphi consensus study.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: December 20, 2023
In Reply to Burton and Hardcastle.
Journal: International journal of radiation oncology, biology, physics
Published: November 09, 2023
A qualitative evaluation of factors influencing Tumor Treating fields (TTFields) therapy decision making among brain tumor patients and physicians.
Journal: BMC cancer
Published: September 29, 2023
Some Like It Hot: The Value of Dose and Hot Spots in Lung Stereotactic Body Radiation Therapy.
Journal: International journal of radiation oncology, biology, physics
Published: March 14, 2023
Recommended first-line management of asymptomatic brain metastases from EGFR mutant and ALK positive non-small cell lung cancer varies significantly according to specialty: an international survey of clinical practice.
Journal: Journal of thoracic disease
Published: May 21, 2022
If at First You Don't Succeed-Stereotactic Body Radiation Therapy for Recurrent Non-Small Cell Lung Cancer.
Journal: International journal of radiation oncology, biology, physics
Published: April 02, 2022
Fast and Furious: New Data Examining Accelerated Radiation Therapy for Limited-Stage Small Cell Lung Cancer.
Journal: International journal of radiation oncology, biology, physics
Published: December 17, 2021
Recommended first-line management of brain metastases from melanoma: A multicenter survey of clinical practice.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: November 22, 2021
Outcomes of patients with stage III non-small cell lung cancer (NSCLC) that harbor a STK11 mutation.
Outcomes of patients with stage III non-small cell lung cancer (NSCLC) that harbor a STK11 mutation.
Journal: Translational lung cancer research
Published: April 04, 2021
Implications of pneumonitis after chemoradiation and durvalumab for locally advanced non-small cell lung cancer.
Journal: Journal of thoracic disease
Published: December 07, 2020
Last Updated: 09/26/2026